Basic Information
Basic information for LINC00343-218-15aa
Peptide Name LINC00343-218-15aa
Genome Position chr13:105728602-105728646[+]
Species Human
Peptide Sequence MKTSKLFIQTNLIIS
Peptide Length 15
Unique No (LINC00343-205-15aa,LINC00343-206-15aa,LINC00343-210-15aa,LINC00343-212-15aa-2,LINC00343-213-15aa,LINC00343-214-15aa-2,LINC00343-217-15aa,LINC00343-219-15aa,LINC00343-220-15aa-2,LINC00343-221-15aa-2,LINC00343-222-15aa,LINC00343-225-15aa,LINC00343-228-15aa-1,LINC00343-229-15aa,LINC00343-231-15aa,LINC00343-234-15aa-2,LINC00343-235-15aa-2,LINC00343-236-15aa,LINC00343-237-15aa-1,LINC00343-239-15aa-2,LINC00343-242-15aa-2,LINC00343-243-15aa-1,LINC00343-245-15aa-2,LINC00343-247-15aa,LINC00343-249-15aa-2,LINC00343-250-15aa-1,LINC00343-256-15aa-2,LINC00343-258-15aa-2,LINC00343-259-15aa-2,LINC00343-263-15aa,LINC00343-265-15aa-2,LINC00343-269-15aa-2,LINC00343-270-15aa-1,LINC00343-273-15aa-1,LINC00343-274-15aa-2,LINC00343-278-15aa-1,LINC00343-279-15aa,LINC00343-280-15aa-2,LINC00343-283-15aa-2,LINC00343-285-15aa-2,LINC00343-287-15aa-3,LINC00343-292-15aa,LINC00343-295-15aa,LINC00343-300-15aa,LINC00343-301-15aa,LINC00343-304-15aa,LINC00343-312-15aa-1,LINC00343-313-15aa,LINC00343-316-15aa-1,LINC00343-319-15aa-2,LINC00343-320-15aa,LINC00343-321-15aa,LINC00343-322-15aa,LINC00343-326-15aa,LINC00343-328-15aa-1,LINC00343-329-15aa,LINC00343-331-15aa)
Grand Average of Hydropathicity 0.5333
Relative Molecular Mass 1989.4
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000654132;LINC00343-218
Transcript Length 2295
Coding Ability 0.4885
DNA Sequence Corresponding to Peptide ATGAAGACTTCGAAGTTATTTATCCAAACCAACCTGATCATTTCT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :